Tenaya Therapeutics (TNYA) Enterprise Value (2020 - 2026)
Tenaya Therapeutics' quarterly Enterprise Value came in at -$80.9 million in Q1 2026, up 8.25% year-on-year from -$74.7 million in Q1 2025, and up 19.55% quarter-over-quarter from -$100.5 million in Q4 2025.
Tenaya Therapeutics has reported Enterprise Value for 7 years, with the latest figure at -$80.9 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 8.25% year-over-year to -$80.9 million; the trailing twelve-month figure through Mar 2026 stood at -$80.9 million (up 8.25% YoY), and the FY2025 full-year result was -$100.5 million, down 63.63% from the prior year.
- Enterprise Value for Q1 2026 stood at -$80.9 million, up from -$100.5 million in the prior quarter.
- The five-year high for Enterprise Value was -$56.3 million in Q3 2025, with the low at -$210.5 million in Q1 2022.
- Average Enterprise Value over 5 years is -$117.8 million, with a median of -$104.6 million recorded in 2023.
- Peak annual rise in Enterprise Value reached 46.71% in 2022, while the deepest fall reached 63.86% in 2022.
- Tracing TNYA's Enterprise Value over 5 years: stood at -$186.5 million in 2022, then surged by 43.9% to -$104.6 million in 2023, then jumped by 41.28% to -$61.4 million in 2024, then slumped by 63.63% to -$100.5 million in 2025, then advanced by 19.55% to -$80.9 million in 2026.
- The last three Enterprise Value figures came in at -$80.9 million (Q1 2026), -$100.5 million (Q4 2025), and -$56.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - | -80.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.89 Mn |
| Dec 31, 2025 | -100.55 Mn |
| Sep 30, 2025 | -56.31 Mn |
| Jun 30, 2025 | -80.70 Mn |
| Mar 31, 2025 | -88.16 Mn |
| Dec 31, 2024 | -61.45 Mn |
| Sep 30, 2024 | -79.47 Mn |
| Jun 30, 2024 | -99.30 Mn |
| Mar 31, 2024 | -122.25 Mn |
| Dec 31, 2023 | -104.64 Mn |
| Sep 30, 2023 | -121.75 Mn |
| Jun 30, 2023 | -132.51 Mn |
| Mar 31, 2023 | -147.81 Mn |
| Dec 31, 2022 | -186.53 Mn |
| Sep 30, 2022 | -149.45 Mn |
| Jun 30, 2022 | -180.92 Mn |
| Mar 31, 2022 | -210.45 Mn |
| Dec 31, 2021 | -251.30 Mn |
| Sep 30, 2021 | -280.47 Mn |
| Jun 30, 2021 | -111.89 Mn |
| Mar 31, 2021 | -128.44 Mn |
| Dec 31, 2020 | -128.54 Mn |
| Sep 30, 2020 | -61.34 Mn |
| Jun 30, 2020 | -40.34 Mn |